On203: The Anti-Oxmif Antibody Targeting Solid Tumors

ON203: the anti-oxMIF antibody targeting solid tumors

The rationale behind the MIF-targeting antibody ON203 for solid tumors

The macrophage migration inhibitory factor (MIF) as a therapeutic and diagnostic target

The Inflammatory Pathogenesis of Cancer-Progress in the Gene Specific Targeting of MIF

Yale Cancer Center

Radiation/IO Combinations to Target Tumour-associated Macrophages, Dr Rachel Evans

CRUK RadNet City of London

Fighting chronic inflammation and cancer with precision

Tumor-derived antibodies for multifaceted immunotherapeutic targeting of human ovarian cancer

The Antibody Society

Targeting Tumor Associated Macrophages in Ovarian Cancer

The Antibody Society

IDE397: a novel MAT2A inhibitor in patients with solid tumors harboring MTAP deletions

Influence of tumor-associated macrophages on pyroptotic cell death in breast cancer

AJE Video Bytes

ALS: Macrophage Migration Inhibitory Factor Reduced Misfolded SOD1 Accumulation and Toxicity...

Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in ad

Alexandros G. Sfakianakis

Redefining Cancer with Integrative Tumor Immunology: Novel Cutting Edge Immunotherapies for Patients

Wolf H. Fridman - Shaping of anti-tumor immunity in the tumor microenvironment

IUIS Immunology Without Borders (IUIS)

Dr. Overmoyer on Inflammatory Triple-Negative Breast Cancer

Research Progress Evaluating the Function and Mechanism of Anti-Tumor Peptides

Dove Medical Press

VT3989YAP, a YAP/TEAD inhibitor, in mesothelioma and NF2-mutant cancers

Dr. Cohen on mTOR Inhibition in Head and Neck Cancer

"Unlocking the Potential of Macrophages in Human Cancer..."

Tumor Immunology

Dr. ANDO Orofacial Pain & Oral Medicine 口腔顔面痛・口腔内科